Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer
- PMID: 16227990
- DOI: 10.1038/nm1310
Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer
Abstract
Immunodeficiency is a barrier to successful vaccination in individuals with cancer and chronic infection. We performed a randomized phase 1/2 study in lymphopenic individuals after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for myeloma. Combination immunotherapy consisting of a single early post-transplant infusion of in vivo vaccine-primed and ex vivo costimulated autologous T cells followed by post-transplant booster immunizations improved the severe immunodeficiency associated with high-dose chemotherapy and led to the induction of clinically relevant immunity in adults within a month after transplantation. Immune assays showed accelerated restoration of CD4 T-cell numbers and function. Early T-cell infusions also resulted in significantly improved T-cell proliferation in response to antigens that were not contained in the vaccine, as assessed by responses to staphylococcal enterotoxin B and cytomegalovirus antigens (P < 0.05). In the setting of lymphopenia, combined vaccine therapy and adoptive T-cell transfer fosters the development of enhanced memory T-cell responses.
Comment in
-
Vaccinating transplant recipients.Nat Med. 2005 Nov;11(11):1162-3. doi: 10.1038/nm1105-1162. Nat Med. 2005. PMID: 16270072 No abstract available.
Similar articles
-
Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma.Blood. 2011 Jan 20;117(3):788-97. doi: 10.1182/blood-2010-08-299396. Epub 2010 Oct 28. Blood. 2011. PMID: 21030558 Free PMC article. Clinical Trial.
-
Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells.Clin Cancer Res. 2014 Mar 1;20(5):1355-65. doi: 10.1158/1078-0432.CCR-13-2817. Epub 2014 Feb 11. Clin Cancer Res. 2014. PMID: 24520093 Free PMC article. Clinical Trial.
-
Rapid immune recovery and graft-versus-host disease-like engraftment syndrome following adoptive transfer of Costimulated autologous T cells.Clin Cancer Res. 2009 Jul 1;15(13):4499-507. doi: 10.1158/1078-0432.CCR-09-0418. Epub 2009 Jun 9. Clin Cancer Res. 2009. PMID: 19509133 Free PMC article. Clinical Trial.
-
T-cell reconstitution and expansion after hematopoietic stem cell transplantation: 'T' it up!Bone Marrow Transplant. 2005 May;35(10):935-42. doi: 10.1038/sj.bmt.1704953. Bone Marrow Transplant. 2005. PMID: 15806121 Review.
-
Immunity for tumors and microbes after autotransplantation: if you build it, they will (not) come.Bone Marrow Transplant. 2006 Feb;37(3):239-47. doi: 10.1038/sj.bmt.1705242. Bone Marrow Transplant. 2006. PMID: 16327812 Review.
Cited by
-
Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions.Clin Dev Immunol. 2012;2012:753407. doi: 10.1155/2012/753407. Epub 2012 May 10. Clin Dev Immunol. 2012. PMID: 22649466 Free PMC article. Review.
-
Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomas.J Neurooncol. 2015 Sep;124(2):307-16. doi: 10.1007/s11060-015-1841-y. Epub 2015 Jun 13. J Neurooncol. 2015. PMID: 26070554 Free PMC article.
-
Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone.Blood. 2007 Oct 1;110(7):2761-3. doi: 10.1182/blood-2007-05-090340. Epub 2007 Jun 19. Blood. 2007. PMID: 17579184 Free PMC article.
-
Immunotherapy for Multiple Myeloma, Past, Present, and Future: Monoclonal Antibodies, Vaccines, and Cellular Therapies.Curr Hematol Malig Rep. 2015 Dec;10(4):395-404. doi: 10.1007/s11899-015-0283-0. Curr Hematol Malig Rep. 2015. PMID: 26338470 Review.
-
Vaccination regimens incorporating CpG-containing oligodeoxynucleotides and IL-2 generate antigen-specific antitumor immunity from T-cell populations undergoing homeostatic peripheral expansion after BMT.Blood. 2007 Jul 1;110(1):450-60. doi: 10.1182/blood-2006-11-057935. Epub 2007 Mar 19. Blood. 2007. PMID: 17371943 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials